References
- Desanctis RW, Hutter AM. Angina pectoris pathophysiology and medical management. In: Eagle KA, ed. The practice of cardiology: the medical and surgical cardiac units at the Massachusetts General Hospital. 2d ed. Boston: Little, Brown, 1989: 359–401
- Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1983: 1(3): 940–5
- Siegel W, Mark D, Hlatky M, et al. Exercise-induced silent ischemia: effect of type A behavior on frequency and prognosis. (Abstr) J Am Coll Cardiol 1989: 13(2): 237A
- Lambert CR, Coy K, Imperi G, et al. Influence of beta-adrenergic blockade defined by time series analysis on circadian variation of heart rate and ambulatory myocardial ischemia. Am J Cardiol 1989: 64(14): 835–9
- CASS Principal Investigators and their associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983: 68(5): 939–50
- Lavie CJ, Ventura HO, Murgo JP. Assessment of stable ischemic heart disease: which tests are best for which patients? Postgrad Med 1991: 89(1): 44–60
- Kaul S, Lilly DR, Gascho JA, et al. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization. Circulation 1988: 77(4): 745–58
- Weiner DA. Risk stratification in angina pectoris. Cardiol Clin 1991: 9(1): 39–47
- Hilton TC, Chaitman BR. The prognosis in stable and unstable angina. Cardiol Clin 1991: 9(1): 27–38
- Hultgren HN, Peduzzi P. Relation of severity of symptoms to prognosis in stable angina pectoris. Am J Cardiol 1984: 54(8): 988–93
- Shub C. Stable angina pectoris. 3. Medical treatment. Mayo Clin Proc 1990: 65(2): 256–73
- Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989: 65(1): 1–21
- Abrams J. Interval therapy to avoid nitrate tolerance: paradise regained? Am J Cardiol 1989: 64(14): 931–4
- Thadani U. The problem of nitrate tolerance: how can it be overcome? J Myocard Ischemia 1990: 2: 13–9
- Miller RR, Olson HG, Amsterdam EA, et al. Propranolol-withdrawal rebound phenomenon: exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med 1975: 293(9): 416–8
- Chan P, Heo J, Garibian G, et al. The role of nitrates, beta blockers, and calcium antagonists in stable angina pectoris. Am Heart J 1988: 116(3): 838–48
- Tolins M, Weir EK, Chesler E, et al. “Maximal” drug therapy is not necessarily optimal in chronic angina pectoris. J Am Coll Cardiol 1984: 3(4): 1051–7
- Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984: 311(21): 1333–9
- Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988: 319(6): 332–7
- Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med 1985: 312(26): 1665–71
- Hammermeister KE, Morrison DA. Coronary bypass surgery for stable angina and unstable angina pectoris. Cardiol Clin 1991: 9(1): 135–55